MICHAEL THOMAS HENDERSON - 10 Jan 2025 Form 4 Insider Report for Spyre Therapeutics, Inc. (SYRE)

Role
Director
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
Issuer symbol
SYRE
Transactions as of
10 Jan 2025
Net transactions value
$0
Form type
4
Filing time
14 Jan 2025, 17:16:29 UTC
Previous filing
10 Jan 2025
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRE Common Stock Other $0 +105,379 $0.000000 105,379 10 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the pro-rata distribution of shares of common stock for no consideration from a limited liability company in which the Reporting Person is a member.

Remarks:

Exhibit 24 - Power of Attorney